Calian Group Ltd. · TSX:CGY
Calian — Q2 2023 Earnings Presentation
14 slides from Calian's earnings presentation, May 11, 2023
Slide 1: Investor Presentation – Q2 FY23
Investor Presentation – Q2 FY23 May 11, 2023
Slide 2: Caution Regarding Forward Looking Statements
Caution Regarding Forward Looking Statements Certain information included in this document is forward-looking and is subject to important risks and uncertainties. The results or events predicted in these statements may differ materially from actual results or events. Such statements are generally ac
Slide 3: Q2-23 Consolidated Results
Q2-23 Consolidated Results $147M $1.2B 6% 13% Gross New Contract Signings Backlog Organic Growth Acquisitive Growth Revenues Gross Profit & Margin Adj. EBITDA1 & Margin1 (in millions of $) (in millions of $, except margin) (in millions of $, except margin) 169 60 40.0% 150 161 52 20.0 19.1 142 148 5
Slide 4: Q2-23 ITCS
Q2-23 ITCS $61M $110M -4% 57% Gross New Contract Signings Backlog Organic Growth Acquisitive Growth Revenues Gross Profit & Margin Adj. EBITDA1 & Margin1 (in millions of $, except margin) (in millions of $, except margin) (in millions of $) 30 65.0% 14.0 35.0% 69 12.4 25.1 60.0% 25 12.0 55.0% 30.0%
Slide 5: Q2-23 Health
Q2-23 Health $25M $681M -4% -% Gross New Contract Signings Backlog Organic Growth Acquisitive Growth Revenues Gross Profit & Margin Adj. EBITDA1 & Margin1 (in millions of $, except margin) (in millions of $, except margin) (in millions of $) 10.0 40.0% 35.0% 14.0 9.0 45 44 8.0 30.0% 40 12.0 11.3 8.0
Slide 6: Q2-23 Advanced Technologies
Q2-23 Advanced Technologies $48M $157M 18% -% Gross New Contract Signings Backlog Organic Growth Acquisitive Growth Gross Profit & Margin Adj. EBITDA1 & Margin1 Revenues (in millions of $, except margin) (in millions of $, except margin) (in millions of $) 47 13.7 45.0% 7.0 14 11.9 6.0 5.7 27.0% 40
Slide 7: Q2-23 Learning
Q2-23 Learning $13M $299M 16% -% Gross New Contract Signings Backlog Organic Growth Acquisitive Growth Gross Profit & Margin Adj. EBITDA1 & Margin1 Revenues (in millions of $, except margin) (in millions of $) (in millions of $, except margin) 29 6.0 40.0% 26 9.0 5.4 5.4 25 8.2 32.0% 8.0 5.0 22 22 6
Slide 8: Q2-23 – Cash Flow
Q2-23 – Cash Flow Operating Free Cash Flow (OCFC)1&2&3 Working Capital Adj. EBITDA2 (in millions of $, except margin) (in millions of $) (in millions of $) 14.1 120% 14.0 13.1 +$6M 19.1 12.0 12.1 100% 16.8 16.8 10.2 10.7 12.4 16.1 85% 14.3 10.0 80% 8.0 78% 74% 8.0 64% 4.1 63% 60% 6.0 40% 4.0 Q2-22 Q
Slide 9: Q2-23 – Capital Deployment
Q2-23 – Capital Deployment Acquisitions Dividends Capex1 (in millions of $) (in millions of $) (in millions of $) 48 3 3 3 3 +$3M 3 2 2 2 2 1 4 3 3 6 Q2-22 Q3-22 Q4-22 Q1-23 Q2-23 Q2-22 Q3-22 Q4-22 Q1-23 Q2-23 Q2-22 Q3-22 Q4-22 Q1-23 Q2-23 1) Capex = Equipment and application software + Capitalized
Slide 10: Q2-23 - Balance Sheet
Q2-23- Balance Sheet Total Debt Cash & Cash Equivalents Net Liquidity (in millions of $) (in millions of $) (in millions of $) 25 130 59 58 124 115 126 114 51 43 46 8 8 8 0 Q2-22 Q3-22 Q4-22 Q1-23 Q2-23 Q2-22 Q3-22 Q4-22 Q1-23 Q2-23 Q2-22 Q3-22 Q4-22 Q1-23 Q2-23 1) Net Liquidity= Unused portion of c
Slide 11: FY23 – Guidance Reiterated
FY23 – Guidance Reiterated Revenues Adj. EBITDA1 Adj. Net Profit1 (in millions of $) (in millions of $) (in millions of $) 630-680 70-75 46-50 582 518 66 44 432 52 37 343 37 24 27 19 2019 2020 2021 2022 2023E 2019 2020 2021 2022 2023E 2019 2020 2021 2022 2023E 1) This is a non-GAAP measure. Please r
Slide 12: Concluding Remarks
Great Q2 performance: = Record revenues =" Gross margin above 30% for fourth consecutive quarter = Highest EBITDA for a second quarter On track for our 6" consecutive record year (revenues, gross profit, EBITDA) Making investments for the long term = Opex investments = Acquisitions Next 3-year strat
Slide 13: Question Period
Question Period Kevin Ford Patrick Houston Jennifer McCaughey CEO CFO & Corporate Secretary Director, Investor Relations
Slide 14: Thank you
See CALIAN . Thank you ir@calian.com